Exact Mass: 487.1786354000001
Exact Mass Matches: 487.1786354000001
Found 79 metabolites which its exact mass value is equals to given mass value 487.1786354000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
stesakine-9-O-beta-D-glucopyranoside
C25H29NO9 (487.18422240000007)
spiruchostatin B
C21H33N3O6S2 (487.18106780000005)
A spiruchostatin with molecular formula C21H33N3O6S2 originally isolated from a Pseudomonas culture broth. D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors
4-hydroxy-3-methoxyphenylacetonitrile 4-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranoside|adenophoraside B
C21H29NO12 (487.16896740000004)
Cys His Gln Thr
C18H29N7O7S (487.18490840000004)
Cys His Thr Gln
C18H29N7O7S (487.18490840000004)
Cys Gln His Thr
C18H29N7O7S (487.18490840000004)
Cys Gln Thr His
C18H29N7O7S (487.18490840000004)
Cys Thr His Gln
C18H29N7O7S (487.18490840000004)
Cys Thr Gln His
C18H29N7O7S (487.18490840000004)
His Cys Gln Thr
C18H29N7O7S (487.18490840000004)
His Cys Thr Gln
C18H29N7O7S (487.18490840000004)
His Met Asn Ser
C18H29N7O7S (487.18490840000004)
His Met Ser Asn
C18H29N7O7S (487.18490840000004)
His Asn Met Ser
C18H29N7O7S (487.18490840000004)
His Asn Ser Met
C18H29N7O7S (487.18490840000004)
His Gln Cys Thr
C18H29N7O7S (487.18490840000004)
His Gln Thr Cys
C18H29N7O7S (487.18490840000004)
His Ser Met Asn
C18H29N7O7S (487.18490840000004)
His Ser Asn Met
C18H29N7O7S (487.18490840000004)
His Thr Cys Gln
C18H29N7O7S (487.18490840000004)
His Thr Gln Cys
C18H29N7O7S (487.18490840000004)
Met His Asn Ser
C18H29N7O7S (487.18490840000004)
Met His Ser Asn
C18H29N7O7S (487.18490840000004)
Met Asn His Ser
C18H29N7O7S (487.18490840000004)
Met Asn Ser His
C18H29N7O7S (487.18490840000004)
Met Ser His Asn
C18H29N7O7S (487.18490840000004)
Met Ser Asn His
C18H29N7O7S (487.18490840000004)
Asn His Met Ser
C18H29N7O7S (487.18490840000004)
Asn His Ser Met
C18H29N7O7S (487.18490840000004)
Asn Met His Ser
C18H29N7O7S (487.18490840000004)
Asn Met Ser His
C18H29N7O7S (487.18490840000004)
Asn Ser His Met
C18H29N7O7S (487.18490840000004)
Asn Ser Met His
C18H29N7O7S (487.18490840000004)
Gln Cys His Thr
C18H29N7O7S (487.18490840000004)
Gln Cys Thr His
C18H29N7O7S (487.18490840000004)
Gln His Cys Thr
C18H29N7O7S (487.18490840000004)
Gln His Thr Cys
C18H29N7O7S (487.18490840000004)
Gln Thr Cys His
C18H29N7O7S (487.18490840000004)
Gln Thr His Cys
C18H29N7O7S (487.18490840000004)
Ser His Met Asn
C18H29N7O7S (487.18490840000004)
Ser His Asn Met
C18H29N7O7S (487.18490840000004)
Ser Met His Asn
C18H29N7O7S (487.18490840000004)
Ser Met Asn His
C18H29N7O7S (487.18490840000004)
Ser Asn His Met
C18H29N7O7S (487.18490840000004)
Ser Asn Met His
C18H29N7O7S (487.18490840000004)
Thr Cys His Gln
C18H29N7O7S (487.18490840000004)
Thr Cys Gln His
C18H29N7O7S (487.18490840000004)
Thr His Cys Gln
C18H29N7O7S (487.18490840000004)
Thr His Gln Cys
C18H29N7O7S (487.18490840000004)
Thr Gln Cys His
C18H29N7O7S (487.18490840000004)
Thr Gln His Cys
C18H29N7O7S (487.18490840000004)
Dacomitinib monohydrate
C24H27ClFN5O3 (487.1786354000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-methylanilino]acetamide
C24H29N3O6S (487.17769740000006)
(2R,3S,3aS,5R,6R,7S,9aS)-5-[(2R,3E,5E,7E)-7-(2,4-dioxopyrrolidin-3-ylidene)-4-methyl-7-oxidohepta-3,5-dien-2-yl]-2,6,9a-trimethyl-8-oxooctahydro-3a,7-epoxyfuro[3,2-b]oxocine-3-carboxylate
C25H29NO9-2 (487.18422240000007)
(2S,3S,3aR,9bR)-N-(cyclopropylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O6S (487.17769740000006)
(2S,3S,3aR,9bR)-N-cyclobutyl-3-(hydroxymethyl)-7-(4-methoxyphenyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O6S (487.17769740000006)
(1R,9S,10S,11S)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-5-(3-methoxyphenyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H29N3O6S (487.17769740000006)
(2R,3R,3aS,9bS)-N-cyclobutyl-3-(hydroxymethyl)-7-(4-methoxyphenyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O6S (487.17769740000006)
2-[(1S,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1R,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
(1S,9R,10R,11R)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-5-(3-methoxyphenyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H29N3O6S (487.17769740000006)
2-[(1R,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1S,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1R,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1S,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1S,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
(2R,3R,3aS,9bS)-N-(cyclopropylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O6S (487.17769740000006)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] nonanoate
nocamycin E(2-)
C25H29NO9 (487.18422240000007)
A monocarboxylic acid anion that is a dianion resulting from the deprotonation of the carboxy group and the enol group of nocamycin E. The major species at pH 7.3.
AZD-8529
C24H24F3N5O3 (487.18311500000004)
AZD-8529 is a potent, highly selective and orally bioavailable positive allosteric modulator of mGluR2, with an EC50 of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes.
(9s,15e,20r)-5,8,18,21-tetrahydroxy-20-methyl-6-(sec-butyl)-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docosa-7,15,18,21-tetraen-3-one
C21H33N3O6S2 (487.18106780000005)
5,8,18,21-tetrahydroxy-20-methyl-6-(sec-butyl)-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docosa-7,15,18,21-tetraen-3-one
C21H33N3O6S2 (487.18106780000005)